Supporting this, nicotinamide N-methyltransferase (NNMT) decreases phosphatase PP2A methylation, which induces EMT via MEK activation in breast cancer cells [54] and promotes migration while increasing ADAMTS6 expression in renal cancer cells [55]. Here, MAP2K7 is linked to breast cancer.